| Public (TSX has Delisted this Stock) | |
| Industry | Biotechnology |
| Headquarters | Montreal, Quebec, Canada |
|
Key people
|
Mark Perrin |
| Products | Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC) |
|
Number of employees
|
44 |
| Website | www.conjuchem.com |
ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Canada which is credited with inventing the experimental peptide hormone CJC-1295.
It employs 45 people, 90% of whom are in research and development.